CELC
Celcuity Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -7.3% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 99 | +6 | 24.27M | $2.54B | +12 | −6 |
| Q1 2026 | 96 | +13 | 18.05M | $2.05B | +17 | −5 |
| Q4 2025 | 83 | -2 | 17.89M | $1.79B | +1 | −2 |
| Q3 2025 | 16 | +3 | 9.73M | $480.43M | +3 | — |
| Q2 2025 | 10 | 0 | 5.98M | $79.79M | +1 | −1 |
| Q1 2025 | 7 | 0 | 2.39M | $24.13M | — | — |
| Q4 2024 | 7 | -1 | 2.58M | $33.71M | +1 | −2 |
| Q3 2024 | 7 | -1 | 1.77M | $26.33M | +1 | −2 |
| Q2 2024 | 8 | — | 1.21M | $19.80M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Citadel Advisors ✦ | 948.43K | +13.4% | $9.59M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 948.43K | +13.4% | $9.59M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 719.92K | +4.0% | $7.28M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 719.92K | +4.0% | $7.28M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | State Street Global Advisors ✦ (passive) | 585.18K | -33.5% | $5.92M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 84.83K | +35.1% | $857,581 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 84.83K | +35.1% | $857,581 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Millennium Management ✦ | 20.35K | -48.7% | $205,749 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 14.13K | +11.1% | $143,000 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 13.38K | -74.2% | $135,252 | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 275 holders, 48.99M shares, $5.37B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
10.0% of class · View original SEC filing ↗